Logo Logo
Group by: Item Type | Date
Jump to: 2022 | 2021 | 2020 | 2018 | 2017 | 2016
Number of items: 11.

2022

Chou, Jinjiang; Kaller, Markus; Jaeckel, Stephanie; Rokavec, Matjaz and Hermeking, Heiko (27. May 2022): AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p. In: Molecular Cancer, Vol. 21 [PDF, 13MB]

Liu, Fangteng; Bouznad, Nassim; Kaller, Markus; Shi, Xiaolong; König, Janine; Jaeckel, Stephanie and Hermeking, Heiko (2022): Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a. In: International Journal of Biological Sciences, Vol. 18, No. 14: pp. 5415-5437 [PDF, 6MB]

Kaller, Markus; Hünten, Sabine; Siemens, Helge and Hermeking, Heiko (2022): Analysis of the p53/microRNA Network in Cancer. In: Schmitz, Ulf; Wolkenhauer, Olaf and Vera-González, Julio (eds.) : Systems Biology of MicroRNAs in Cancer. Advances in Experimental Medicine and Biology, Vol. 1385. Cham: Springer. pp. 187-228

Wirth, Anna-Katharina; Wange, Lucas; Vosberg, Sebastian; Henrich, Kai-Oliver; Rausch, Christian; Oezdemir, Erbey; Zeller, Christina M.; Richter, Daniel; Feuchtinger, Tobias; Kaller, Markus; Hermeking, Heiko; Greif, Philipp A.; Senft, Daniela; Jurinovic, Vindi; Bahrami, Ehsan; Jayavelu, Ashok Kumar; Westermann, Frank; Mann, Matthias; Enard, Wolfgang; Herold, Tobias and Jeremias, Irmela (2022): In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance. In: Leukemia, Vol. 36: pp. 2863-2874

2021

Jackstadt, Rene; Kaller, Markus; Menssen, Antje and Hermeking, Heiko (2021): Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing. In: Soucek, Laura and Whitfield, Jonathan (eds.) : The Myc Gene. Methods in Molecular Biology, Vol. 2318. pp. 119-160

2020

Shi, Xiaolong; Kaller, Markus; Rokavec, Matjaz; Kirchner, Thomas; Horst, David and Hermeking, Heiko (2020): Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer. In: Cellular and Molecular Gastroenterology and Hepatology, Vol. 10, No. 2: pp. 391-418

2018

Lamprecht, Sebastian; Kaller, Markus; Schmidt, Eva Marina; Blaj, Cristina; Schiergens, Tobias S.; Engel, Jutta; Jung, Andreas; Hermeking, Heiko; Grünewald, Thomas G. P.; Kirchner, Thomas and Horst, David (2018): PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer. In: Clinical cancer research, Vol. 24, No. 8: pp. 1974-1986

Jaeckel, Stephanie; Kaller, Markus; Jackstadt, Rene; Götz, Ursula; Müller, Susanna; Boos, Sophie; Horst, David; Jung, Peter and Hermeking, Heiko (2018): Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells. In: Nature Communications, Vol. 9, 3573 [PDF, 3MB]

Oener, Meryem Guelfem; Rokavec, Matjaz; Kaller, Markus; Bouznad, Nassim; Horst, David; Kirchner, Thomas and Hermeking, Heiko (2018): Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1. In: Gastroenterology, Vol. 155, No. 6: pp. 1868-1882

2017

Rokavec, Matjaz; Kaller, Markus; Horst, David and Hermeking, Heiko (2017): Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. In: Scientific Reports, Vol. 7, 4687 [PDF, 6MB]

2016

Kaller, Markus and Hermeking, Heiko (2016): Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer. In: Slaby, Ondrej and Calin, George A. (eds.) : Non-coding RNAs in Colorectal Cancer. Advances in Experimental Medicine and Biology, Vol. 937. Cham: Springer. pp. 71-92

This list was generated on Fri Apr 12 03:03:53 2024 CEST.